Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method
- PMID: 22912385
- PMCID: PMC3482164
- DOI: 10.1161/CIRCRESAHA.112.273144
Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method
Abstract
Rationale: Cardiomyocytes (CMs) differentiated from human pluripotent stem cells (PSCs) are increasingly being used for cardiovascular research, including disease modeling, and hold promise for clinical applications. Current cardiac differentiation protocols exhibit variable success across different PSC lines and are primarily based on the application of growth factors. However, extracellular matrix is also fundamentally involved in cardiac development from the earliest morphogenetic events, such as gastrulation.
Objective: We sought to develop a more effective protocol for cardiac differentiation of human PSCs by using extracellular matrix in combination with growth factors known to promote cardiogenesis.
Methods and results: PSCs were cultured as monolayers on Matrigel, an extracellular matrix preparation, and subsequently overlayed with Matrigel. The matrix sandwich promoted an epithelial-to-mesenchymal transition as in gastrulation with the generation of N-cadherin-positive mesenchymal cells. Combining the matrix sandwich with sequential application of growth factors (Activin A, bone morphogenetic protein 4, and basic fibroblast growth factor) generated CMs with high purity (up to 98%) and yield (up to 11 CMs/input PSC) from multiple PSC lines. The resulting CMs progressively matured over 30 days in culture based on myofilament expression pattern and mitotic activity. Action potentials typical of embryonic nodal, atrial, and ventricular CMs were observed, and monolayers of electrically coupled CMs modeled cardiac tissue and basic arrhythmia mechanisms.
Conclusions: Dynamic extracellular matrix application promoted epithelial-mesenchymal transition of human PSCs and complemented growth factor signaling to enable robust cardiac differentiation.
Figures
Similar articles
-
Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.Methods Mol Biol. 2016;1353:163-80. doi: 10.1007/7651_2014_178. Methods Mol Biol. 2016. PMID: 25626427
-
Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells.Methods Mol Biol. 2011;767:419-31. doi: 10.1007/978-1-61779-201-4_31. Methods Mol Biol. 2011. PMID: 21822893 Free PMC article.
-
Generation of Cardiomyocytes from Pluripotent Stem Cells.Methods Mol Biol. 2016;1353:181-90. doi: 10.1007/7651_2014_173. Methods Mol Biol. 2016. PMID: 25523811
-
Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.Life Sci. 2016 Jan 15;145:98-113. doi: 10.1016/j.lfs.2015.12.023. Epub 2015 Dec 10. Life Sci. 2016. PMID: 26682938 Review.
-
The electrophysiological development of cardiomyocytes.Adv Drug Deliv Rev. 2016 Jan 15;96:253-73. doi: 10.1016/j.addr.2015.12.023. Adv Drug Deliv Rev. 2016. PMID: 26788696 Review.
Cited by
-
Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists.Cardiovasc Eng Technol. 2024 Jan 16. doi: 10.1007/s13239-023-00707-w. Online ahead of print. Cardiovasc Eng Technol. 2024. PMID: 38228811 Review.
-
Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1.Mol Ther Nucleic Acids. 2023 Oct 19;34:102060. doi: 10.1016/j.omtn.2023.102060. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 38028197 Free PMC article.
-
Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia.Stem Cell Res Ther. 2023 Jul 27;14(1):183. doi: 10.1186/s13287-023-03405-5. Stem Cell Res Ther. 2023. PMID: 37501071 Free PMC article.
-
Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes.Theranostics. 2023 Jul 3;13(11):3872-3896. doi: 10.7150/thno.80801. eCollection 2023. Theranostics. 2023. PMID: 37441603 Free PMC article.
-
Role and Mechanism of BMP4 in Regenerative Medicine and Tissue Engineering.Ann Biomed Eng. 2023 Jul;51(7):1374-1389. doi: 10.1007/s10439-023-03173-6. Epub 2023 Apr 4. Ann Biomed Eng. 2023. PMID: 37014581 Review.
References
-
- Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O’Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007;25:1015–1024. - PubMed
-
- Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LJ, Keller GM. Human cardiovascular progenitor cells develop from a kdr+ embryonic-stem-cell-derived population. Nature. 2008;453:524–528. - PubMed
-
- Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, Ellis J, Keller G. Stage-specific optimization of activin/nodal and bmp signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011;8:228–240. - PubMed
-
- Elliott DA, Braam SR, Koutsis K, Ng ES, Jenny R, Lagerqvist EL, Biben C, Hatzistavrou T, Hirst CE, Yu QC, Skelton RJ, Ward-van Oostwaard D, Lim SM, Khammy O, Li X, Hawes SM, Davis RP, Goulburn AL, Passier R, Prall OW, Haynes JM, Pouton CW, Kaye DM, Mummery CL, Elefanty AG, Stanley EG. Nkx2-5(egfp/w) hescs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods. 2011;8:1037–1040. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
